References
1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 2011; 123: e18–e209.
2. Yancy CW. Heart failure in African Americans. Am J Cardiol 2005; 96: 3i–12i.
3. Yancy CW, Strong M. The natural history, epidemiology, and prognosis of heart failure in African Americans. Congest Heart Fail 2004; 10: 15–18.
4. Bibbins-Domingo K, Pletcher MJ, Lin F, et al. Racial differences in incident heart failure among young adults. N Engl J Med 2009; 360: 1179–1190.
5. Okin PM, Kjeldsen SE, Dahlof B, et al. Racial differences in incident heart failure during antihypertensive therapy. Circ Cardiovasc Qual Outcomes 2011; 4: 157–164.
6. Husaini BA, Mensah GA, Sawyer D, et al. Race, sex, and age differences in heart failure-related hospitalizations in a southern state: implications for prevention. Circ Heart Fail 2011; 4: 161–169.
8. Chen J, Normand SL, Wang Y, et al. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998–2008. JAMA 2011; 306: 1669–1678.
9. Tennessee Department of Health and Tennessee State University, Center for Health Research.Tennessee Heart Disease and Stroke Prevention and Care Plan 2008-2012. Nashville, TN, Tennessee Department of Health, 2007.
10. Fuster V, Smaha L. AHA’s new strategic impact goal designed to curb epidemic of cardiovascular disease and stroke. Circulation 1999; 99: 2360.
11. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154–e235.
12. Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation 2010; 121: 586–613.
14. Fang J, Mensah GA, Croft JB, et al. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol 2008; 52: 428–434.
15. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Stat Notes 2001: 1–10.
16. Kozak LJ, DeFrances CJ, Hall MJ. National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13 2006; 162: 1–209.
17. Chen J, Normand SL, Wang Y, et al. Recent declines in hospitalizations for acute myocardial infarction for Medicare fee-for-service beneficiaries: progress and continuing challenges. Circulation 2010; 121: 1322–1328.
18. Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. New Engl J Med 2010; 362: 2155–2165.
19. Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation 2005; 112: 1651–1662.
20. Dunlay SM, Weston SA, Jacobsen SJ, et al. Risk factors for heart failure: a population-based case-control study. Am J Med 2009; 122: 1023–1028.
21. Witzig R. The medicalization of race: scientific legitimization of a flawed social construct. Ann Intern Med 1996; 125: 675–679.
22. Schwartz RS. Racial profiling in medical research. N Engl J Med 2001; 344: 1392–1393.
23. AAA statement on race. Am Anthropol 1998; 100: 712–713.
24. Manolio TA, Burke GL, Savage PJ, et al. Exercise blood pressure response and 5-year risk of elevated blood pressure in a cohort of young adults: the CARDIA study. Am J Hypertens 1994; 7: 234–241.
25. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med 1989; 149: 780–788.
26. Apostolides AY, Cutter G, Daugherty SA, et al. Three-year incidence of hypertension in thirteen U.S. communities. Prev Med 1982; 11: 487–499.
27. Johnson AL, Cornoni JC, Cassel JC, et al. Influence of race, sex and weight on blood pressure behavior in young adults. Am J Cardiol 1975; 35: 523–530.
28. Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1979; 242: 2572–2577.
30. Buchowski MS, Cohen SS, Matthews CE, et al. Physical activity and obesity gap between black and white women in the southeastern U.S. Am J Prev Med 2010; 39: 140–147.
31. Signorello LB, Hargreaves MK, Blot WJ. The Southern Community Cohort Study: investigating health disparities. J Health Care Poor Underserved 2010; 21: 26–37.
32. Heart Failure Society of America. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 2006; 12: 10–38.
33. Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 2003; 163: 525–541.
34. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252.
35. Franciosa JA, Ferdinand KC, Yancy CW. Treatment of heart failure in African Americans: a consensus statement. Congest Heart Fail 2010; 16: 27–38.
36. Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension 2010; 56: 780–800.
37. Taylor AL, Ziesche S, Yancy C, et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 2004; 351: 2049–2057.
38. Rust G, Satcher D, Fryer GE, et al. Triangulating on success: innovation, public health, medical care, and cause-specific US mortality rates over a half century (1950-2000). Am J Public Health 2010; 100 (1 suppl): S95–S104.